Increased expression of these genes (except PLXNA4) was associated with worse prognosis for PFI, which could be due to their higher expression either in aggressive molecular subtypes (PLXNA1 and PLXNA2) or immune infiltrate subtypes (NRP1, NRP2, and PLXNA1) or high association with tumor infiltrates (NRP1, NRP2, and PLXNA1) (Figure 3, Figure S2 and Figure 7A–C). The gene discussed is NRP2; the disease is neoplasm.